Table 2.
Logistics analyses of clinical factors associated with DKD in patients with T2D.
| Variables | Model I | Model II | ||
|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | |
| SBP | 1.02 (1.02- 1.03) | < 0.001 | 1.02 (1.01 - 1.03) | < 0.001 |
| DBP | 1.01 (1.00 - 1.03) | 0.038 | 1.01 (0.99 - 1.02) | 0.206 |
| BMI | 1.07 (1.03 - 1.11) | 0.001 | 1.04 (0.99 - 1.08) | 0.089 |
| HbA1c | 1.07 (1.00 - 1.14) | 0.043 | 1.10 (1.02 - 1.18) | 0.009 |
| LDL-C | 0.97 (0.82 - 1.14) | 0.700 | – | – |
| HDL-C | 0.85 (0.54 - 1.34) | 0.487 | – | – |
| TG | 1.27 (1.15 - 1.40) | < 0.001 | 1.28 (1.15 - 1.42) | < 0.001 |
| FBG | 1.04 (0.99 - 1.09) | 0.136 | – | – |
| TyG index | 1.55 (1.26 - 1.90) | < 0.001 | 1.57 (1.26 - 1.94) | < 0.001 |
| TyG-BMI (per SD) | 1.37 (1.18 - 1.60) | < 0.001 | 1.27 (1.08 - 1.49) | 0.004 |
Model I was adjusted for age and sex. Model II was adjusted for age, gender, hypertension, diabetic duration, and ACEI/ARB usage. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; DBP, diastolic blood pressure; SBP, systolic blood pressure; BMI, body mass index; HbA1c, glycated hemoglobin; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; TG, triglycerides; TyG, triglyceride glucose; TyG-BMI, triglyceride glucose index × body mass index; DKD, diabetic kidney disease.